Zonegran (Concordia Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Zonegran drug offered from Concordia Pharmaceuticals Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Concordia Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | zonisamide |
| SUBSTANCE NAME: | ZONISAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-03-27 |
| END MARKETING DATE: | 0000-00-00 |
Zonegran HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zonegran from Concordia Pharmaceuticals Inc. |
| LABELER NAME: | Concordia Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2000-03-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59212-680_a33e18b7-8453-45c9-8bd2-957d126c7eed |
| PRODUCT NDC: | 59212-680 |
| APPLICATION NUMBER: | NDA020789 |
Other ZONISAMIDE Pharmaceutical Manufacturers / Labelers:
